Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
Norihiko Takahashi, Takayuki Ohkuri, Shigenori Homma, et al.
Cancer Science (2012) Vol. 103, Iss. 1, pp. 150-153
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima, et al.
Cancer Science (2017) Vol. 108, Iss. 10, pp. 1947-1952
Open Access | Times Cited: 212
Trial watch
Erika Vacchelli, Isabelle Martins, Alexander Eggermont, et al.
OncoImmunology (2012) Vol. 1, Iss. 9, pp. 1557-1576
Open Access | Times Cited: 169
Next‐generation peptide vaccines for advanced cancer
Akira Yamada, Tetsuro Sasada, Masanori Noguchi, et al.
Cancer Science (2012) Vol. 104, Iss. 1, pp. 15-21
Open Access | Times Cited: 128
Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review
Eva van Doorn, Heng Liu, Anke Huckriede, et al.
Human Vaccines & Immunotherapeutics (2015) Vol. 12, Iss. 1, pp. 159-169
Open Access | Times Cited: 114
Colorectal cancer vaccines: Tumor-associated antigensvsneoantigens
Sandra Wagner, Christina Susanne Mullins, Michael Linnebacher
World Journal of Gastroenterology (2018) Vol. 24, Iss. 48, pp. 5418-5432
Open Access | Times Cited: 104
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi, et al.
Cancer Immunology Immunotherapy (2016) Vol. 65, Iss. 2, pp. 193-204
Open Access | Times Cited: 96
The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?
Alaa Alsalloum, Julia Shevchenko, С. В. Сенников
Cancers (2023) Vol. 15, Iss. 6, pp. 1779-1779
Open Access | Times Cited: 27
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
Mina Hosseini, Simin Seyedpour, Behzad Khodaei, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 146-146
Open Access | Times Cited: 25
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
Neil L. Berinstein, Mohan Karkada, Michael A. Morse, et al.
Journal of Translational Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 77
MAGE-A antigens as targets for cancer immunotherapy
Erik van Schooten, Alessia Di Maggio, Paul M.P. van Bergen en Henegouwen, et al.
Cancer Treatment Reviews (2018) Vol. 67, pp. 54-62
Open Access | Times Cited: 69
Advances in the study of HLA-restricted epitope vaccines
Lingxiao Zhao, Min Zhang, Hua Cong
Human Vaccines & Immunotherapeutics (2013) Vol. 9, Iss. 12, pp. 2566-2577
Open Access | Times Cited: 59
Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
Yujie Zhang, Yuxin Zhang, Li Zhang
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 2, pp. 281-291
Open Access | Times Cited: 50
Therapeutic vaccines and cancer: focus on DPX-0907
Mohan Karkada, Marc Mansour, Neil L. Berinstein
Biologics (2014), pp. 27-27
Open Access | Times Cited: 47
MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1
Kunio Iura, Kenichi Kohashi, Takeaki Ishii, et al.
Virchows Archiv (2017) Vol. 471, Iss. 3, pp. 383-392
Closed Access | Times Cited: 43
Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
Weijian Zhu, Qiang Yi, Zheng Chen, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Peptide Immunotherapy in Vaccine Development
Hyun Mo Yang, Dong Seok Kim
Advances in protein chemistry and structural biology (2015), pp. 1-14
Closed Access | Times Cited: 36
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Lifeng Hu, Huanrong Lan, Dong Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
Advances in immunotherapy for pancreatic ductal adenocarcinoma
Motoki Miyazawa, Masahiro Katsuda, Manabu Kawai, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2021) Vol. 28, Iss. 5, pp. 419-430
Open Access | Times Cited: 24
Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models
Kouichi Furugaki, Lin Cui, Yumi Kunisawa, et al.
PLoS ONE (2014) Vol. 9, Iss. 7, pp. e101854-e101854
Open Access | Times Cited: 30
Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
Danyang Wang, Hangyu Zhang, Tao Xiang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Potential role of 5-Aza-2′-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer
Viswanath Gunda, Alexandria P. Cogdill, Maria Bernasconi, et al.
Surgery (2013) Vol. 154, Iss. 6, pp. 1456-1462
Open Access | Times Cited: 30
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
Junya Ohtake, Takayuki Ohkuri, Yuji Togashi, et al.
Immunology Letters (2014) Vol. 161, Iss. 1, pp. 20-30
Closed Access | Times Cited: 28
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
Nada Hradilova, Lenka Sadílková, Ondřej Palata, et al.
PLoS ONE (2017) Vol. 12, Iss. 2, pp. e0171539-e0171539
Open Access | Times Cited: 26
A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma
Rong Li, Jiao Gong, Cuicui Xiao, et al.
Genomics (2020) Vol. 112, Iss. 6, pp. 5101-5114
Open Access | Times Cited: 23
A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia
Yukio Kobayashi, Toru Sakura, Shuichi Miyawaki, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 7, pp. 851-863
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top